Responses
Liver
Adiponectin and its receptors in non-alcoholic steatohepatitis
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 16 March 2005
- Published on: 16 March 2005Adiponectin receptor II in non-alcoholic fatty liver diseaseShow More
Dear Editor,
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and metabolic syndrome. The histological spectrum of NAFLD includes fatty liver to non-alcoholic steatohepatitis (NASH). Adipocyte-derived factors might play a role in the progression of the disease. Of these, adiponectin has been reported to alleviate NAFLD in an animal model [1], and its plasma level is reduced in patients w...
Conflict of Interest:
None declared.